Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori-induced gastric mucosal damage in Mongolian gerbils

Aim: To investigate the effectiveness of 4 d' anti-Helicobacter pyloritherapy on the H pylori-infected Mongolian gerbils based on physiological and pathological changes. Methods: We used 6-wk-old male gerbils orally inoculated with H pylori (ATCC43504, 2×10⁸ CFU/mL). Seven weeks after H pylori inoculation, the animals of study group received 4 d' anti-H pyloritriple therapy (H pylori-eradicated group). Seven days later, all animals of the H pylori-eradicated and control groups ( H pylori-infected & H pylori-uninfected groups) were sacrificed. We examined gastric mucosal lesions macroscopically, studied gastritis microscopically and determined the stomach weight ratio, myeloperoxidase (MPO) activity and prostaglandin (PG) E₂ level. Results: The results showed that both macroscopic and histological gastric damages were significantly less in H pylori-eradicated group than H pylori-infected group. Stomach weight ratio, MPO activity and PGE₂ levels were significantly higher in H pylori-infected group than those in the other two groups. Conclusion: Four days' anti-H pylori therapy was effective in the improvement of H pylori-induced gastric lesions in Mongolian gerbils.